1. Frieri M, Kumar K, Boutin A. Antibiotic resistance. J
Infect Public Health. 2017;10(4):369-78.
2.Wang H, Li J, Tao W, Zhang X, Gao X, Yong J, et al.
Lycium ruthenicum studies: molecul biol,
phytochemistry and pharmacol. Food Chem
2018;240:759-66.
3. Hasan S. A review on nanoparticles: their synthesis and
types. Res J Recent Sci.2015;2277:2502.
4. Xu L, Wang Y-Y, Huang J, Chen C-Y, Wang Z-X, Xie
H. Silver nanoparticles: Synthesis, medical applications
and biosafety. Theranostics. 2020;10(20):8996.
5.Yin IX, Zhang J, Zhao IS, Mei ML, Li Q, Chu CH. The
antibacterial mechanism of silver nanoparticles and its
application in dentistry. Int J Nanomed 2020;15:2555.
6. Rao S, Kang X, Li J, Chen J. Induction, identification
and characterization of tetraploidy in Lycium
ruthenicum. Breed Sci 2019;18144.
7. Franci G, Falanga A, Galdiero S, Palomba L, Rai M,
Morelli G, et al. Silver nanoparticles as potential
antibacterial agents. Molecules 2015;20(5):8856-74.
8. Inweregbu K, Dave J, Pittard A. Nosocomial infections.
Continuing Education in Anaesthesia, Crit Care Pain.
2005;5(1):147.
9. Emori TG, Gaynes RP. An overview of nosocomial
infections, including the role of the microbiology
laboratory. Clin Microbiol Rev. 1993;6(4):428-42.
10. Zabihi M, Eghbaliferiz S, Khorashadizadeh M,
Mortazavi-Derazkola S, Yousefi M. Green synthesis of
non-toxic silver nanoparticles using Salvia tebesana
Bunge extract: Optimization, cytotoxicity, and
antibacterial activities. Results Chem. 2024;7: 101510.
11. Sikora A, Zahra F. Nosocomial infections. 2023;
StatPearls [Internet]: Available from:
https://www.ncbi.nlm.nih.gov/books/NBK559312/
12. Darvishi M, Forootan M, Nazer MR, Karimi E, Noori
M. Nosocomial Infections, Challenges and Threats: A
Review Article. Iranian J Med Microbiol
2020;14(2):162-81.
13. Samuel S, Kayode O, Musa O, Nwigwe G, Aboderin
A, Salami T, et al. Nosocomial infections and the
challenges of control in developing countries. African J
Clin Exp Microbiol 2010;11(2).102-10.
14. Guzman M, Dille J, Godet S. Synthesis and
antibacterial activity of silver nanoparticles against
gram-positive and gram-negative bacteria. Nanomed.
2012;8(1):37-45.
15. Seibert G, Hörner R, Meneghetti BH, Righi RA, Forno
NLFD, Salla A. Nosocomial infections by Klebsiella
pneumoniae carbapenemase producing enterobacteria in
a teaching hospital. Einstein (São Paulo). 2014;12:282-
6.
16. Allocati N, Masulli M, Alexeyev MF, Di Ilio C.
Escherichia coli in Europe: an overview. Int J Environ
Res Public Health. 2013;10(12):6235-54.
17. Obritsch MD, Fish DN, MacLaren R, Jung R.
Nosocomial infections due to multidrug‐resistant
Pseudomonas aeruginosa: epidemiology and treatment
options. Pharmacotherapy: J Human Pharmacol Drug
Ther. 2005;25(10):1353-64.
18. Kao PHN, Kline KA. Dr. Jekyll and Mr. Hide: how
Enterococcus faecalis subverts the host immune
response to cause infection. J Molecular Biol.
2019;43(16):2932-45.
19. Kramer TS, Schröder C, Behnke M, Aghdassi SJ,
Geffers C, Gastmeier P, Remschmidt C. Decrease of
methicillin resistance in Staphylococcus aureus in
nosocomial infections in Germany-a prospective
analysis over 10 years. J Infect 2019;78(3):215-19.
20. Aslam B, Wang W, Arshad MI, Khurshid M,
Muzammil S, Rasool MH, et al. Antibiotic resistance: a
rundown of a global crisis. Infect Drug Resist
2018;11:1645.
21. Yelin I, Kishony R. Antibiotic resistance. Cell.
2018;172(5);1136.
22. Sultan I, Rahman S, Jan AT, Siddiqui MT, Mondal
AH, Haq QMR. Antibiotics, resistome and resistance
mechanisms: a bacterial perspective. Front Microbiol.
2018;9:2066.
23. Wilson DN, Hauryliuk V, Atkinson GC, O’Neill AJ.
Target protection as a key antibiotic resistance
mechanism. Nat Rev Microbiol 2020;18(11):637-48.
24.Sahoo N, Manchikanti P, Dey S. Herbal drugs:
standards and regulation. Fitoterapia. 2010;81(6):462-
71.
25. Zheng J, Ding C, Wang L, Li G, Shi J, Li H, et al.
Anthocyanins composition and antioxidant activity of
wild Lycium ruthenicum Murr. from Qinghai-Tibet
Plateau. Food Chemis. 2011;126(3):859-65.
26. Valizadeh H, Mahmoodi Kordi F, Koohkan R,
Bahadori MB, Moridi Farimani M. Isolation and
structure elucidation of coumarin and cinamate
derivatives from Lycium ruthenicum. Iran Chem
Commun. 2014;2(4):236-325.
27. Koohkan r, mahmoudikordi f, bahadori m, valizadeh
h. phytochemical investigation of lycium ruthenicum
from iran. 3rd National Cong Med Plant. 2014.
28. Jiang Y, Fang Z, Leonard W, Zhang P. Phenolic
compounds in Lycium berry: Composition, health
benefits and industrial applications. J Func Foods
2021;126(3):859-65.
29. Panigrahi S, Kundu S, Ghosh S, Nath S, Pal T. General
method of synthesis for metal nanoparticles. J
Nanoparticle Res. 2004;6(4):411-4.
30. Mulfinger L, Solomon SD, Bahadory M,
Jeyarajasingam AV, Rutkowsky SA, Boritz C.
Synthesis and study of silver nanoparticles. J Chem Edu.
2007;84(2):322.
31. Wei L, Lu J, Xu H, Patel A, Chen Z-S, Chen G. Silver
nanoparticles: synthesis, properties, and therapeutic
applications. Drug Dis Today. 2015;20(5):595-601.
32. Abbasi E, Milani M, Fekri Aval S, Kouhi M,
Akbarzadeh A, Tayefi Nasrabadi H, et al. Silver
nanoparticles: synthesis methods, bio-applications and
properties. Critic Rev Microbiol. 2016;42(2):173-80.
33. Abou El-Nour KM, Eftaiha Aa, Al-Warthan A,
Ammar RA. Synthesis and applications of silver
nanoparticles. Arab j of chem. 2010;3(3):135-40.
34. Ghorbani HR, Safekordi AA, Attar H, Sorkhabadi S.
Biological and non-biological methods for silver
nanoparticles synthesis. Chem Biochem Engin Quarter
2011;25(3):317-26.
35. Singh R, Shedbalkar UU, Wadhwani SA, Chopade
BA. Bacteriagenic silver nanoparticles: synthesis,
mechanism, and applications. Applie Microbiol
Biotechnol. 2015;99(11):4579-93.
36. Askarifar f, Shafaie E, Sedighi M, Tavakoli kareshk
A. Green Synthesis of SilverNanoparticles by
Hypericum perforatum extract and Berberine and
Evaluation of Their Antibacterial Effects. J Ardabil
Univ Med Sci 2023;23(2):262-2
مجله علوم پزشکی پارس